Role of bariatric surgery in diabetes

Current Cardiology Reports

Volumn 16, Issue 2, 2014, Pages

  Poirier, Paul ^a   Auclair, Audrey ^a  

^a LAVAL UNIVERSITY   (Canada)

Author keywords

Bariatric surgery; Diabetes remission; Non surgical duodenal exclusion; Obesity; Type 2 diabetes; Weight loss

Indexed keywords

BARIATRIC SURGERY; BILIOPANCREATIC BYPASS; BODY MASS; CLINICAL EFFECTIVENESS; COMORBIDITY; DISEASE ASSOCIATION; FOLLOW UP; GASTRIC BANDING; HUMAN; INCIDENCE; INSULIN RESISTANCE; LAPAROSCOPIC SLEEVE GASTRECTOMY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RELAPSE; REMISSION; REVIEW; RISK REDUCTION; SLEEVE GASTRECTOMY; SYSTEMATIC REVIEW (TOPIC); TREATMENT INDICATION; TREATMENT OUTCOME; WEIGHT GAIN; WEIGHT REDUCTION; METHODOLOGY; RECURRENT DISEASE;

BARIATRIC SURGERY; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; HUMANS; OBESITY; RECURRENCE; REMISSION INDUCTION; TREATMENT OUTCOME;

EID: 84891702210     PISSN: 15233782     EISSN: 15343170     Source Type: Journal    
DOI: 10.1007/s11886-013-0444-5     Document Type: Review

References (37)

1. Livingston EH, Ko CY. Effect of diabetes and hypertension on obesity-related mortality. Surgery. 2005;137:16-25. (Pubitemid 40029371)
2. Campbell RK, Martin TM. The chronic burden of diabetes. Am J Manag Care. 2009;15:S248-54.
3. Despres JP, Poirier P. Diabetes: Looking back at Look AHEAD-giving lifestyle a chance. Nat Rev Cardiol 2013.
4. Wing RR, Bolin P, Brancati FL, Bray GA, Clark JM, Coday M, et al. Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes. N Engl J Med. 2013;369(2):145-54.
5. •• Poirier P, Cornier MA, Mazzone T, et al. Bariatric surgery and cardiovascular risk factors: a scientific statement from the American Heart Association. Circulation. 2011;123:1683-701. American Heart Association scientific statement regarding bariatric surgery and management of cardiovascular risk factors.
6. Encinosa WE, Bernard DM, Steiner CA, Chen CC. Use and costs of bariatric surgery and prescription weight-loss medications. Health Aff (Millwood). 2005;24:1039-46. (Pubitemid 41058604)
7. Thaler JP, Cummings DE. Minireview: Hormonal and metabolic mechanisms of diabetes remission after gastrointestinal surgery. Endocrinology. 2009;150:2518-25.
8. Rubino F, Schauer PR, Kaplan LM, Cummings DE. Metabolic surgery to treat type 2 diabetes: clinical outcomes and mechanisms of action. Annu Rev Med. 2010;61:393-411.
9. Vest AR, Heneghan HM, Agarwal S, Schauer PR, Young JB. Bariatric surgery and cardiovascular outcomes: a systematic review. Heart. 2012;98:1763-77.
10. Standards of medical care in diabetes - 2013. Diabetes Care 2013;36 Suppl 1:S11-S66.
11. Dixon JB, Zimmet P, Alberti KG, Rubino F. Bariatric surgery: an IDF statement for obese Type 2 diabetes. Diabet Med. 2011;28:628-42.
12. •• Rubino F, Kaplan LM, Schauer PR, Cummings DE. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg. 2010;251:399-405. Consensus from expert in the field of bariatric surgery regarding bariatric surgeryin the management of patient with type 2 diabetes.
13. Runkel N, Colombo-Benkmann M, Huttl TP, et al. Evidence-based German guidelines for surgery for obesity. Int J Colorectal Dis. 2011;26:397-404.
14. Poirier P, Alpert MA, Fleisher LA, et al. Cardiovascular evaluation and management of severely obese patients undergoing surgery: a science advisory fromthe American Heart Association. Circulation. 2009;120:86-95.
15. Colquitt JL, Picot J, Loveman E, Clegg AJ. Surgery for obesity. Cochrane Database Syst Rev 2009;CD003641.
16. Renard E. Bariatric surgery in patients with late-stage type 2 diabetes: expected beneficial effects on risk ratio and outcomes. Diabetes Metab. 2009;35:564-8.
17. Buchwald H, Estok R, Fahrbach K, et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med. 2009;122:248-56.
18. Dixon JB, O'Brien PE, Playfair J, et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA. 2008;299:316-23. (Pubitemid 351159368)
19. •• Schauer PR, Kashyap SR, Wolski K, et al. Bariatric surgery versus intensive medical therapy in obese patients with diabetes. N Engl J Med. 2012;366:1567-76. A landmark randomized controlled trials comparing RYGB and sleeve gastrectomy with medical therapy to treat type 2 diabetes.
20. •• Mingrone G, Panunzi S, De GA, et al. Bariatric surgery versus conventional medical therapy for type 2 diabetes. N Engl J Med. 2012;366:1577-85. A landmark randomized controlled trials comparing RYGB and BPD with medical therapy to treat type 2 diabetes.
21. Buchwald H, Avidor Y, Braunwald E, et al. Bariatric surgery: a systematic review and meta-analysis. JAMA. 2004;292:1724-37. (Pubitemid 39346675)
22. Nannipieri M, Mari A, Anselmino M, et al. The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery. J Clin Endocrinol Metab. 2011;96:E1372-9.
23. Chiellini C, Rubino F, Castagneto M, Nanni G, Mingrone G. The effect of bilio-pancreatic diversion on type 2 diabetes in patients with BMI <35 kg/m2. Diabetologia. 2009;52:1027-30.
24. Dirksen C, Jorgensen NB, Bojsen-Moller KN, et al. Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass. Diabetologia. 2012;55:1890-901.
25. Laferrere B. Diabetes remission after bariatric surgery: is it just the incretins? Int J Obes (Lond). 2011;35 Suppl 3:S22-5.
26. Mingrone G, Castagneto-Gissey L. Mechanisms of early improvement/ resolution of type 2 diabetes after bariatric surgery. Diabetes Metab. 2009;35:518-23.
27. Johnson BL, Blackhurst DW, Latham BB, et al. Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus. J Am Coll Surg. 2013;216:545-56.
28. Romeo S, Maglio C, Burza MA, et al. Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes. Diabetes Care. 2012;35:2613-7.
29. Sjostrom L, Lindroos AK, Peltonen M, et al. Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery. N Engl J Med. 2004;351:2683-93. (Pubitemid 39665322)
30. Adams TD, Davidson LE, Litwin SE, et al. Health benefits of gastric bypass surgery after 6 years. JAMA. 2012;308:1122-31.
31. Arterburn DE, Bogart A, Sherwood NE, et al. A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass. Obes Surg. 2013;23:93-102.
32. Maggard-Gibbons M, Maglione M, Livhits M, et al. Bariatric surgery for weight loss and glycemic control in nonmorbidly obese adults with diabetes: a systematic review. JAMA. 2013;309:2250-61.
33. Sandoval D. Bariatric surgeries: beyond restriction and malabsorption. Int J Obes (Lond). 2011;35 Suppl 3:S45-9.
34. Rodriguez-Grunert L, Galvao Neto MP, Alamo M, Ramos AC, Baez PB, Tarnoff M. First human experience with endoscopically delivered and retrieved duodenal-jejunal bypass sleeve. Surg Obes Relat Dis. 2008;4:55-9.
35. Tarnoff M, Rodriguez L, Escalona A, et al. Open label, prospective, randomized controlled trial of an endoscopic duodenal-jejunal bypass sleeve versus low calorie diet for pre-operative weight loss in bariatric surgery. Surg Endosc. 2009;23:650-6.
36. Gersin KS, Rothstein RI, Rosenthal RJ, et al. Open-label, sham-controlled trial of an endoscopic duodenojejunal bypass liner for preoperative weight loss in bariatric surgery candidates. Gastrointest Endosc. 2010;71:976-82.
37. Johnson RJ, Johnson BL, Blackhurst DW. Bariatric surgery is associated with a reduced risk of mortality in morbidly obese patients with a history of major cardiovascular events. Am Surg. 2012;78(6):685-92.